Effects of Hydroxychloroquine Plus Favipiravir Treatment on the Clinical Course and Biomarkers in Hospitalized COVID-19 Patients with Pneumonia

Effects of Hydroxychloroquine Plus Favipiravir Treatment on the Clinical Course and Biomarkers in Hospitalized COVID-19 Patients with Pneumonia

Background: The novel coronavirus disease 2019 (COVID-19) has a broad spectrum of clinical manifestations, the most common serious clinical manifestation of the coronavirus infection being pneumonia. Unfortunately, the optimal treatment approach is still uncertain. However, many studies have been...

Full description

Bibliographic Details
Main Authors: Leman Acun Delen, Abdullah Gok, Umut Sabri Kasapoğlu, Ozlem Cagasar, Zarife Gok, Nurcan Berber, Serdar Derya, Bora Tetik
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2022-01-01
Series:Acta Clinica Croatica
Subjects:
Favipiravir
Hydroxychloroquine
COVID-19
SARS-COV-2
Pneumonia
Online Access:https://hrcak.srce.hr/file/428402

Similar Items

Similar Items